Compare Sea Limited (SE) vs TG Therapeutics Inc (TGTX) Price & Performance

Sea LimitedTrade

TG Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Sea Limited vs TG Therapeutics Inc — how do they compare? Sea Limited trades at $106.26 (market cap $64.73B), while TG Therapeutics Inc trades at $54.06 (market cap $8.26B). The key difference: Sea Limited is far larger — about 7.8× TG Therapeutics Inc's market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Sea Limited nearer its low. Which is the better fit depends on your goals.

	SE	TGTX
Market Cap	$64.73B	$8.26B
Sector	Media	Health
52-Week High	$196.50	$59.06
52-Week Low	$78.16	$26.39
Enterprise Value	$57.78B	$8.50B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

Sea Limited stock drops 32% despite stronger fundamentals, seen as market disconnect by analystSeeking Alpha · 16 hours agoBullish Sea Limited posts $7B revenue and $1B EBITDA in Q1 2026, showing strong growth and profitability.Seeking Alpha · 4 days agoBullish View details →

TGTX

Law firm investigates TG Therapeutics officers for possible self-dealing harming shareholdersGlobeNewsWire · 5 days agoBearish View details →

About Sea Limited

Sea Limited offers information technology services. The Company provides online personal computer and mobile digital content, e-commerce, and payment platforms. Sea serves customers worldwide.

About TG Therapeutics Inc

TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.